Clomid Side Effects: Label Data, Vision Warnings and Risks
Clomid side effects from the FDA label: hot flushes, bloating, vision changes, ovarian hyperstimulation, twins and the effects reported in men.
Clomid Side Effects at a Glance
Most Clomid side effects are mild and pass once the 5-day course ends, but a few are serious enough that every patient should know them. The most reliable numbers come from the FDA prescribing label for Clomid (clomiphene citrate), which pooled adverse reactions from 8,029 women in clinical studies.
Clomid side effects reported in the FDA label (8,029 women)
Ovarian enlargement
13.6%
Ovaries grow as follicles develop
Hot flushes (vasomotor flushes)
10.4%
Sudden warmth, usually brief
Abdominal or pelvic discomfort, bloating
5.5%
Often linked to ovarian enlargement
Nausea and vomiting
2.2%
Usually mild
Breast discomfort
2.1%
Tenderness during the cycle
Visual symptoms
1.5%
Blurring, spots or flashes; see below
Headache
1.3%
Usually mild
Abnormal uterine bleeding
1.3%
Spotting or heavier bleeding
The two effects that need the most attention are not the most common ones. Visual disturbances can be permanent, and ovarian hyperstimulation can become dangerous within days. Both are covered below, along with the risk of twins and the side effects reported in men, who take Clomid off label. For how the drug produces these effects, see how Clomid works.
The Clomid label warns that visual disturbances "may be irreversible, especially with increased dosage or duration of therapy."
Vision Changes: The Warning to Take Seriously
Blurred vision, spots or flashes of light (called scintillating scotomata) were reported by 1.5% of women in the label data. The label states that the chance of these symptoms rises with higher doses and longer treatment, and that they may be irreversible.
That is why the standard advice is simple: anyone who notices blurring, flashes, spots, shadows or loss of part of the visual field while taking Clomid should stop the drug and have an eye examination. Driving or operating machinery can also be affected while symptoms last.
Men who take Clomid off label face the same risk. In a study of 400 men treated for low testosterone (Krzastek and colleagues, Journal of Urology, 2019), blurred vision was among the most common reported side effects. A published case report (Alizadeh and colleagues, 2021) describes a 33-year-old man who developed optic nerve damage on day 14 of 100 mg daily taken for fertility, a dose higher than the 25 to 50 mg used in most male studies.
Ovarian Hyperstimulation Syndrome
Ovarian hyperstimulation syndrome (OHSS) happens when the ovaries respond too strongly. The Clomid label notes that it can progress rapidly, within 24 hours to several days, and that severe cases involve marked ovarian enlargement, fluid in the abdomen (ascites), shortness of breath, reduced urine output and fluid around the lungs. The label also reports deaths from hypovolemic shock and thromboembolism in severe cases. It does not give an incidence rate for Clomid.
Warning signs that need same-day medical contact during or after a Clomid cycle:
- 1Severe or worsening pain or swelling in the abdomen or pelvis
- 2Rapid weight gain over a few days
- 3Shortness of breath
- 4Passing much less urine than usual
- 5Nausea and vomiting that do not settle
Mild bloating and pelvic discomfort are common and usually settle on their own. The difference is severity and speed, which is why fertility clinics monitor response with ultrasound.
Twins and Multiple Pregnancy
Multiple pregnancy is a side effect in the practical sense: it raises risks for both mother and babies. The Clomid label reports multiple pregnancies in 7.98% of pregnancies in its clinical studies, made up of twins 6.9%, triplets 0.5%, quadruplets 0.3% and quintuplets 0.1%.
In the PPCOS II trial of 750 women with polycystic ovary syndrome (Legro and colleagues, New England Journal of Medicine, 2014), twins occurred in 7.4% of clomiphene pregnancies compared with 3.4% with letrozole, a difference that did not reach statistical significance. The full comparison is in our Clomid vs letrozole guide.
The label advises against going beyond 100 mg a day for 5 days, and against more than about six cycles of treatment in total.
Clomid Side Effects in Men
The FDA label covers only women, but it notes that "testicular tumors and gynecomastia have been reported in males using clomiphene." Data on men come from published studies of off-label use for low testosterone and infertility.
Reported rates vary with how carefully symptoms were recorded. In the Krzastek study, 8% of 400 men reported side effects, most often mood changes, blurred vision and breast tenderness, with no serious adverse events. In a 2024 study that asked about specific symptoms (Saffati and colleagues, Translational Andrology and Urology), 47% of men on clomiphene reported at least one side effect, including decreased libido in 33.3%, reduced energy in 16.7%, mood changes in 9.1% and gynecomastia in 3%.
Estradiol usually rises in men on Clomid. One study of 15 men on long-term treatment found it doubled, from 17 to 34 pg/mL. Details and dosing are in Clomid side effects in men. The single-isomer drug enclomiphene was developed partly to reduce these effects; see enclomiphene side effects.
Who Should Not Take Clomid
The label lists situations in which Clomid should not be used:
- 1Pregnancy or suspected pregnancy
- 2Liver disease or a history of liver dysfunction
- 3Abnormal uterine bleeding of undetermined cause
- 4Ovarian cysts or enlargement not due to polycystic ovary syndrome
- 5Uncontrolled thyroid or adrenal disorders
- 6An organic intracranial lesion such as a pituitary tumor
- 7Known allergy to clomiphene
Clomid is a prescription-only drug in the US. A prescriber checks these conditions before starting and should be told about any new symptom during treatment, especially visual changes, severe abdominal pain or sudden shortness of breath.
Frequently Asked Questions
In the FDA label data from 8,029 women, the most common were ovarian enlargement (13.6%), hot flushes (10.4%), abdominal or pelvic discomfort and bloating (5.5%), nausea and vomiting (2.2%) and breast discomfort (2.1%). Most are mild and settle after the 5-day course ends.
It can. Visual symptoms such as blurring, spots and flashes were reported in 1.5% of women in the label data, and the label warns they may be irreversible, especially with higher doses or longer treatment. Anyone with vision changes on Clomid should stop the drug and see an eye doctor.
The Clomid label reports multiple pregnancy in 7.98% of pregnancies, mostly twins at 6.9%, with triplets 0.5% and rarer higher multiples. In the PPCOS II trial, twins occurred in 7.4% of clomiphene pregnancies compared with 3.4% on letrozole, and the label advises against doses above 100 mg a day.
It is an excessive ovarian response that the Clomid label says can develop within 24 hours to several days. Severe cases cause major abdominal swelling, fluid build-up, breathlessness and reduced urine. Severe pain, rapid weight gain or shortness of breath during a cycle needs same-day medical contact.
Yes. Studies report mood changes, blurred vision, breast tenderness, lower libido and rising estradiol. A study of 400 men found side effects in 8%, while a 2024 study that asked directly found them in 47% of men on clomiphene. The label notes gynecomastia and testicular tumors have been reported in men.
Most do, since the common effects such as hot flushes and bloating are tied to the treatment cycle. Visual disturbances are the exception, because the label warns they may be permanent. Zuclomiphene, one of Clomid's two isomers, can stay in the body for more than a month after a dose.
Clomid.org is an independent educational resource. We are not affiliated with any pharmaceutical manufacturer, compounding pharmacy, telehealth company or healthcare provider. This content is for informational purposes only and does not constitute medical advice. Images on this site are illustrative artwork made for editorial purposes; they do not show real products, packaging or labels and are not an advertisement or an offer to sell.